Literature DB >> 18421762

Role of probiotic therapy in IBD.

Kim Isaacs1, Hans Herfarth.   

Abstract

There is mounting evidence that probiotic therapy may alter disease expression in both animal models of IBD and in patients with IBD. The effects appear to be modest at best and may reflect the choice of probiotic organism, the variability in concentrations of organisms administered, and the variability of the diseases being treated. This review examines the data of all fully published articles currently available for the role of probiotics in the treatment of IBD.

Entities:  

Mesh：

Year:  2008        PMID： 18421762     DOI： 10.1002/ibd.20465

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


  30 in total

Review 1.  Role of the gut microbiota in defining human health.

Authors:  Kei E Fujimura; Nicole A Slusher; Michael D Cabana; Susan V Lynch
Journal:  Expert Rev Anti Infect Ther       Date:  2010-04       Impact factor: 5.091

Review 2.  Costimulation of Th17 cells: Adding fuel or putting out the fire in the inflamed gut?

Authors:  Zili Zhang; James T Rosenbaum; Wenwei Zhong; Carmen Lim; David J Hinrichs
Journal:  Semin Immunopathol       Date:  2010-01-30       Impact factor: 9.623

Review 3.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

4.  Activation of Natural Killer Cells by Probiotics.

Authors:  Nabil Aziz; Benjamin Bonavida
Journal:  For Immunopathol Dis Therap       Date:  2016

Review 5.  Optimizing conventional therapies for inflammatory bowel disease.

Authors:  Miles P Sparrow; Peter M Irving; Stephen B Hanauer
Journal:  Curr Gastroenterol Rep       Date:  2009-12

6.  The probiotic Lactobacillus plantarum counteracts TNF-{alpha}-induced downregulation of SMCT1 expression and function.

Authors:  Alip Borthakur; Arivarasu N Anbazhagan; Anoop Kumar; Geetu Raheja; Varsha Singh; Krishnamurthy Ramaswamy; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-29       Impact factor: 4.052

Review 7.  Why is initial bacterial colonization of the intestine important to infants' and children's health?

Authors:  Pearl D Houghteling; W Allan Walker
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-03       Impact factor: 2.839

8.  Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy.

Authors:  Erika Mileti; Gianluca Matteoli; Iliyan D Iliev; Maria Rescigno
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

Review 9.  Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases.

Authors:  Christopher D Packey; R Balfour Sartor
Journal:  Curr Opin Infect Dis       Date:  2009-06       Impact factor: 4.915

10.  Post-translational inhibition of IP-10 secretion in IEC by probiotic bacteria: impact on chronic inflammation.

Authors:  Gabriele Hoermannsperger; Gabriele Hörmannsperger; Thomas Clavel; Micha Hoffmann; Caroline Reiff; Denise Kelly; Gunnar Loh; Michael Blaut; Gabriele Hölzlwimmer; Melanie Laschinger; Dirk Haller
Journal:  PLoS One       Date:  2009-02-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.